Endogenous MicroRNA Competition as a Mechanism of shRNA-Induced Cardiotoxicity

Area of Science:

• Molecular Biology
• Gene Therapy
• Biochemistry

Background:

• Short hairpin RNAs (shRNAs) are used for gene knockdown but can cause toxicity.
• Excessive shRNA can interfere with endogenous microRNA (miRNA) processing.
• Understanding the impact of shRNA on miRNA profiles is crucial for therapeutic safety.

Purpose of the Study:

• To investigate the effects of excessive shRNA on muscle miRNA expression.
• To compare the host response to shRNA delivery in cardiac versus other muscle tissues.
• To identify mechanisms underlying shRNA-induced toxicity and potential protective factors.

Main Methods:

• Mice were treated with recombinant adeno-associated viral vectors (rAAVs) expressing shRNAs.
• Small RNA sequencing was performed on muscle and liver tissues.
• Quantification of shRNA and miRNA levels was conducted.

Main Results:

• Highest shRNA expression and cardiomyopathy were observed in the heart when shRNAs comprised over 51% of small RNAs.
• Other muscle tissues showed lower shRNA accumulation (around 12%) with less toxicity.
• Predominant cardiac miRNAs remained stable, while miR-451 levels correlated with shRNA load and toxicity.
• Cardiac tissue demonstrated a protective mechanism for maintaining miRNA levels, contrasting with liver tissue responses.

Conclusions:

• Cardiac tissue exhibits a protective mechanism against shRNA-induced miRNA disruption, unlike the liver.
• MiRNA profiling after excessive shRNA delivery is key to understanding host response.
• This knowledge facilitates the development of safer and more effective therapeutic gene knockdown strategies.